Drug Encapsulation

Performance of AGO™ Encapsulating

BSA with Affinity and Efficiency

Drug Encapsulation-01
Drug Encapsulation-02

AGO™ Encapsulation Efficiency (EE) of

T-mAb Targeting, Paclitaxel & Curcumin Dual Drug

Drug Encapsulation-11
Drug Encapsulation-12

AGO™ Injectable Gel Degradation In-Vivo

•AGOTM injectable with ICG contrast agent, using  IVIS imaging, 7-week-old female Balb/c Nu mice , n =3
•AGO™ injectables can be degraded in–vivo over a time period of 7 days, which ca be designed by matching the drug release profile over the same time duration

Drug Delivery-5

 *Indocyanine green (ICG) is a FDA-approved cyanine dye used in medical diagnostics